[vc_row][vc_column][vc_custom_heading text=”EASL School: Clinical problems in management of cirrhosis and portal hypertension related complications” font_container=”tag:h2|font_size:28|text_align:left|color:%23826b6a” use_theme_fonts=”yes”][vc_empty_space height=”10px”][vc_column_text]The objective of the School is to foster the clinical formation of young hepatologists in the area of advanced liver disease, and in particular in the field of portal hypertension, where important advancements are in progress. The School is scheduled for 2022, following on the Baveno 7 consensus conference on portal hypertension, where new statements and related clinical practice guidelines were expected.

The School will focus on complications related to portal hypertension, which constitute most of the complex clinical problems in the management of patients with advanced liver disease. These include diuretic-refractory ascites, frequently recurrent hepatic encephalopathy, antibiotic-resistant bacterial infections, and the management of patients eligible for transplantation, but who fall outside the MELD criteria. [/vc_column_text][vc_empty_space height="10px"][easl_generic_button new_tab="true" color="orange" i_align="left" i_icon_fontawesome="far fa-hand-pointer" add_icon="true" title="Access the programme" url="https://easl.websitestage.co.uk/wp-content/uploads/2021/03/EASL-Schools-2022-Management-of-cirrhosis-programme.pdf%22][vc_empty_space height="10px"][vc_custom_heading text="Learning objectives" font_container="tag:h2|font_size:28|text_align:left|color:%23826b6a" use_theme_fonts="yes"][vc_empty_space height="10px"][vc_column_text]

• To foster the clinical formation in portal hypertension 
• To obtain a comprehensive view of the complexities of advanced liver disease and its treatment 

[/vc_column_text][vc_empty_space height=”10px”][vc_custom_heading text=”Target audience” font_container=”tag:h2|font_size:28|text_align:left|color:%23826b6a” use_theme_fonts=”yes”][vc_empty_space height=”10px”][vc_column_text]

• Hepatologists
• Clinical Scientists
• Transplant hepatologists 

[/vc_column_text][vc_empty_space height=”10px”][vc_custom_heading text=”Top 3 reasons to attend” font_container=”tag:h2|font_size:28|text_align:left|color:%23826b6a” use_theme_fonts=”yes”][vc_empty_space height=”10px”][vc_column_text]

• The presence of a group of experts covering the full range of complications related to portal hypertension 
• The timing of the School after the latest Baveno consensus conference, held in 2021 
• The variety of selected topics, that cover most aspects of advanced liver disease 

[/vc_column_text][/vc_column][/vc_row]